The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Open accessAbstract
BACKGROUND: The cancer stem cell theory hypothesizes that cancers are perpetuated by cancer stem cells (CSC) or tumor initiating cells (TIC) possessing self-renewal and other stem cell-like properties while differentiated non-stem/initiating cells have a finite life span. To investigate whether the hypothesis is applicable to lung cancer, identification of lung CSC and demonstration of these capacities is essential. METHODOLOGY/PRINCIPAL FINDING: The expression profiles of five stem cell markers (CD34, CD44, CD133, BMI1 and OCT4) were screened by flow cytometry in 10 lung cancer cell lines. CD44 was further investigated by testing for in vitro and in vivo tumorigenecity. Formation of spheroid bodies and in vivo tumor initiation ability were demonstrated in CD44(+) cells of 4 cell lines. Serial in vivo tumor transplantability in nude mice was demonstrated using H1299 cell line. The primary xenografts initiated from CD44(+) cells consisted of mixed CD44(+) and CD44(-) cells in similar ratio as the parental H1299 cell line, supporting in vivo differentiation. Semi-quantitative Real-Time PCR (RT-PCR) showed that both freshly sorted CD44(+) and CD44(+) cells derived from CD44(+)-initiated tumors expressed the pluripotency genes OCT4/POU5F1, NANOG, SOX2. These stemness markers were not expressed by CD44(-) cells. Furthermore, freshly sorted CD44(+) cells were more resistant to cisplatin treatment with lower apoptosis levels than CD44(-) cells. Immunohistochemical analysis of 141 resected non-small cell lung cancers showed tumor cell expression of CD44 in 50.4% of tumors while no CD34, and CD133 expression was observed in tumor cells. CD44 expression was associated with squamous cell carcinoma but unexpectedly, a longer survival was observed in CD44-expressing adenocarcinomas. CONCLUSION/SIGNIFICANCE: Overall, our results demonstrated that stem cell-like properties are enriched in CD44-expressing subpopulations of some lung cancer cell lines. Further investigation is required to clarify the role of CD44 in tumor cell renewal and cancer propagation in the in vivo environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 5×
“Expression of the key ‘stemness’ genes of embryonic (ES) and inducedpluripotent stem (iPS) cells OCT4 and BMI1 [9,10] have been found in CSC from different cancers [11,12].”
BackgroundInfluentialIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,723
Identification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., & De Maria, R. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells
Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N.-S., Jackson, K. W., Suri, P., & Wicha, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0054 · Cited by 1,244
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 947
Oct4-Induced Pluripotency in Adult Neural Stem Cells
Kim, J. B., Sebastiano, V., Wu, G., Araúzo-Bravo, M. J., Sasse, P., Gentile, L., Ko, K., Ruau, D., Ehrich, M., van den Boom, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.023 · Cited by 934
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Jiang, F., Qiu, Q., Khanna, A., Todd, N. W., Deepak, J., Xing, L., Wang, H., Liu, Z., Su, Y., Stass, S. A., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0393 · Cited by 788
Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905653106 · Cited by 767
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1034 · Cited by 588
Zhang, J., Tam, W.-L., Tong, G. Q., Wu, Q., Chan, H.-Y., Soh, B.-S., Lou, Y., Yang, J., Ma, Y., Chai, L., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1481 · Cited by 568
Self-citationCD44 is required for two consecutive steps in HGF/c-Met signaling
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Chen, Y.-C., Hsu, H.-S., Chen, Y.-W., Tsai, T.-H., How, C.-K., Wang, C.-Y., Hung, S.-C., Chang, Y.-L., Tsai, M.-L., Lee, Y.-Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002637 · Cited by 508
Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B., & Farrar, W. L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604242 · Cited by 437
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Levina, V., Marrangoni, A. M., DeMarco, R., Gorelik, E., & Lokshin, A. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003077 · Cited by 407
Tam, I. Y. S., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C. M., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1981 · Cited by 400
Self-citationSetting Standards for Human Embryonic Stem Cells
Brivanlou, A. H., Gage, F. H., Jaenisch, R., Jessell, T., Melton, D., & Rossant, J. (2003) · Science · doi:10.1126/science.1082940 · Cited by 323
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
Toole, B. P., & Slomiany, M. G. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.009 · Cited by 220
Tirino, V., Camerlingo, R., Franco, R., Malanga, D., La Rocca, A., Viglietto, G., Rocco, G., & Pirozzi, G. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.03.063 · Cited by 213
CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
Haraguchi, N., Ohkuma, M., Sakashita, H., Matsuzaki, S., Tanaka, F., Mimori, K., Kamohara, Y., Inoue, H., & Mori, M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0074-0 · Cited by 211
Modern Flow Cytometry: A Practical Approach
Tung, J. W., Heydari, K., Tirouvanziam, R., Sahaf, B., Parks, D. R., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.05.001 · Cited by 207
Self-citationCD44 and EpCAM: Cancer-Initiating Cell Markers
Marhaba, R., Klingbeil, P., Nuebel, T., Nazarenko, I., Buechler, M., & Zoeller, M. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733667 · Cited by 192
Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Toole, B. P., & Slomiany, M. G. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.04.002 · Cited by 182
Zeilstra, J., Joosten, S. P. J., Dokter, M., Verwiel, E., Spaargaren, M., & Pals, S. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2940 · Cited by 179
Aldehyde dehydrogenase activity as a functional marker for lung cancer
Ucar, D., Cogle, C. R., Zucali, J. R., Ostmark, B., Scott, E. W., Zori, R., Gray, B. A., & Moreb, J. S. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.029 · Cited by 171
Expression of CD44 in human lung tumors
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92213-6 · Cited by 161
Bourguignon, L., Gilad, E., & Peyrollier, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610054200 · Cited by 152
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Gutova, M., Najbauer, J., Gevorgyan, A., Metz, M. Z., Weng, Y., Shih, C.-C., & Aboody, K. S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000243 · Cited by 141
Jaksch, M., Múnera, J. O., Bajpai, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0723 · Cited by 137
Gai, H., Leung, E. L., Costantino, P. D., Aguila, J. R., Nguyen, D., Fink, L. M., Ward, D. C., & Ma, Y. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.08.008 · Cited by 133
Self-citationSelectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells
Napier, S. L., Healy, Z. R., Schnaar, R. L., & Κωνσταντόπουλος, Κ. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607219200 · Cited by 116
Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
Ma, L., Lai, D., Liu, T., Cheng, W., & Guo, L. (2010) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq067 · Cited by 112
Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
Stuelten, C. H., Mertins, S. D., Busch, J. I., Theofiles, M., Scudiero, D. A., Burkett, M. W., Hite, K. M., Alley, M., Hollingshead, M. G., Shoemaker, R. H., et al. (2010) · Stem Cells · doi:10.1002/stem.324 · Cited by 105
CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.
Madjd, Z., Mehrjerdi, A. Z., Sharifi, A. M., Molanaei, S., Shahzadi, S. Z., & Asadi‐Lari, M. (2009) · PubMed · Cited by 97
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Kwai‐Yee, S. (2007) · The HKU Scholars Hub (University of Hong Kong) · doi:10.5353/th_b3955753 · Cited by 83
The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer
Basak, S. K., Veena, M. S., Oh, S., Huang, G., Srivatsan, E. S., Huang, M., Sharma, S. P., & Batra, R. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005884 · Cited by 65
Separating Stem Cells by Flow Cytometry: Reducing Variability for Solid Tissues
Alexander, C. M., Puchalski, J. R., Klos, K. S., Badders, N. M., Ailles, L., Kim, C. F., Dirks, P. B., & Smalley, M. J. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.11.008 · Cited by 64
Lam, D. C.-L., Girard, L., Suen, W., Chung, L., Tin, V. P., Lam, W.-K., Minna, J. D., & Wong, M. P. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31624-5 · Cited by 41
Self-citation
Cited by
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Stem cell programs in cancer initiation, progression, and therapy resistance
Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524
Understanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
Metadata
- Authors
- Leung, E. L.-H., Fiscus, R. R., Tung, J. W., Tin, V. P.-C., Cheng, L. C., Sihoe, A. D.-L., Fink, L. M., Ma, Y., & Wong, M. P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-19
- Volume
- 5
- Issue
- 11
- Pages
- e14062
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2152627545
- Cited by
- 473
- References
- 46
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.